GuangYuYuan Chinese Herbal Medicine Co (SHSE:600771) Research & Development: ¥36 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600771 GuangYuYuan Chinese Herbal Medicine Co Ltd SHSE:600771
52 GF Score
Price ¥15.04
GF Value ¥24.06
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is GuangYuYuan Chinese Herbal Medicine Co Research & Development?

GuangYuYuan Chinese Herbal Medicine Co SHSE:600771 -4.87% 52 Research & Development is ¥36 Mil as of Mar. 2026. GuruFocus rates SHSE:600771 with a GF Score™ of 52/100 and a GF Value™ of ¥24.06 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. GuangYuYuan Chinese Herbal Medicine Co's Research & Development for the three months ended in Mar. 2026 was ¥10 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥36 Mil.

GuangYuYuan Chinese Herbal Medicine Co  (SHSE:600771) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

GuangYuYuan Chinese Herbal Medicine Co Research & Development Related Terms

GuangYuYuan Chinese Herbal Medicine Co Research & Development Historical Data

* Premium members only.

The historical data trend for GuangYuYuan Chinese Herbal Medicine Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GuangYuYuan Chinese Herbal Medicine Co Research & Development Chart

GuangYuYuan Chinese Herbal Medicine Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.19 28.96 31.38 38.59 38.47

GuangYuYuan Chinese Herbal Medicine Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.34 8.38 10.32 7.42 10.11
SHSE:600771
52GF Score
GuangYuYuan Chinese Herbal Medicine Co Ltd SHSE:600771
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GuangYuYuan Chinese Herbal Medicine Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥36 Mil mean?
GuangYuYuan Chinese Herbal Medicine Co (SHSE:600771) has a Research & Development of ¥36 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on GuangYuYuan Chinese Herbal Medicine Co and its competitors.
Is GuangYuYuan Chinese Herbal Medicine Co's Research & Development too high?
GuangYuYuan Chinese Herbal Medicine Co's current Research & Development is ¥36 Mil. Overall, GuangYuYuan Chinese Herbal Medicine Co has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GuangYuYuan Chinese Herbal Medicine Co's Research & Development compare to LLY and JNJ?
GuangYuYuan Chinese Herbal Medicine Co's Research & Development of ¥36 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on GuangYuYuan Chinese Herbal Medicine Co and its competitors. GuangYuYuan Chinese Herbal Medicine Co's current Research & Development is ¥36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GuangYuYuan Chinese Herbal Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, GuangYuYuan Chinese Herbal Medicine Co (SHSE:600771) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥24.06, compared to a current price of ¥15.04 — trading 37.5% below its estimated fair value. The current Research & Development is ¥36 Mil. GuangYuYuan Chinese Herbal Medicine Co's overall GF Score™ is 52/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For GuangYuYuan Chinese Herbal Medicine Co (SHSE:600771), the current Research & Development is ¥36 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GuangYuYuan Chinese Herbal Medicine Co (SHSE:600771) Overvalued in 2026?

Based on GuruFocus' analysis, GuangYuYuan Chinese Herbal Medicine Co stock appears to be undervalued. The current stock price of ¥15.04 is trading 37.5% below its estimated GF Value™ of ¥24.06. GuruFocus considers GuangYuYuan Chinese Herbal Medicine Co to be Significantly Undervalued.

Key valuation signals for SHSE:600771:

  • Research & Development: ¥36 Mil
  • GF Value™: ¥24.06 vs. price of ¥15.04 (37.5% below fair value)
  • GF Score™: 52/100 with 1 warning sign

No single metric tells the full story. See the SHSE:600771 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GuangYuYuan Chinese Herbal Medicine Co Business Description

Address Gaoxin 6th Road, High-tech Zone, No. 52, Liren Technology Park, Building A, 6th Floor, Xi\'an, Shaanxi, CHN
GuangYuYuan Chinese Herbal Medicine Co Ltd distributes pharmaceutical products. Its products include far plate turtle age wine bottle, niuhuang qingxin pills, boutique angong niuhuang wan, modified turtle age wine, ding kundan, and many more.
52GF Score

Get the complete analysis for SHSE:600771

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.04
Price
¥24.06
GF Value